JT
James Kenneth Timmis
Novartis / GSK Vaccines, Vrije Universiteit Amsterdam, Imperial College London, University of Freiburg
Research areas: Social Sciences · Education · Vaccine Coverage and Hesitancy · Science Education and Pedagogy · Science and Education Research
0000-0002-7773-0859
Employment
-
Novartis / GSK Vaccines Research internship with Dr. Rino Rappuoli2014 - 2015
Education
-
Vrije Universiteit Amsterdam PhD in Stakeholder-centred Healthcare Innovation2019 - 2021
-
Imperial College London MSc in Health Policy2016 - 2018
-
Albert-Ludwigs-Universität Freiburg BA in Political Science2011 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (26)
- Patient Priorities for Digital Biomarkers in Cardiovascular Risk Management: Survey Study (Preprint) Save
- “Solidarity is No One-Way Street” – The Effects of COVID-19 Framings on Attitudes Towards Cost-Sharing for Inpatient Treatment in Germany Save
- Toward Patient-Centric Digital Monitoring of Obstructive Sleep Apnea: Mixed Methods Study Save
- Toward Patient-Centric Digital Monitoring of Obstructive Sleep Apnea: Mixed Methods Study (Preprint) Save
- How Can ‘Health in All Policies’ Help Maximise the Potential of Microbial Biotechnologies for Health, Equity and Sustainability? Save
- Economic and health consequence frames affect COVID-19 vaccine incentive attitudes in Germany– a survey based framing experiment Save
- Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany Save
- Guidelines to support the design, and selection and appraisal of multimedia teaching aids for microbiology education Save
- Weaponising microbes for peace Save
- Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy Save
- Left–Right‐Position, party affiliation and regional differences explain low COVID‐19 vaccination rates in Germany Save
- Innovations for microbiome targeting interventions - a patent landscape analysis indicating overall patenting activity decline and promising target disease areas. Save
- Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives. Save
- Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions Save
- Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study Save
- Strategies to minimize preventable morbidity and mortality resulting from pandemics like COVID-19. Save
- The urgent need for microbiology literacy in society: children as educators. Save
- The urgent need for microbiology literacy in society. Save
- Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities. Save
- Improving accountability in vaccine decision-making Save